We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.52B
AUM Growth
-$173M
Cap. Flow
-$49.9M
Cap. Flow %
-1.98%
Top 10 Hldgs %
37.25%
Holding
3,473
New
219
Increased
908
Reduced
1,468
Closed
292

Sector Composition

Rank Sector Weight
1 Technology 15.38%
2 Financials 8.17%
3 Healthcare 7.07%
4 Consumer Discretionary 4.99%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLGT icon
3226
Radiant Logistics
RLGT
$395M
-140
Closed -$1K
RNAM
3227
DELISTED
Avidity Biosciences
RNAM
-171
Closed -$4K
RNAC icon
3228
Cartesian Therapeutics
RNAC
$268M
$0 ﹤0.01%
3
RNP icon
3229
Cohen & Steers REIT and Preferred and Income Fund
RNP
$989M
$0 ﹤0.01%
3
ROCK icon
3230
Gibraltar Industries
ROCK
$1.49B
-2
Closed
RRR icon
3231
Red Rock Resorts
RRR
$3.62B
-36
Closed -$2K
RSI icon
3232
Rush Street Interactive
RSI
$2.88B
-61
Closed -$1K
RWR icon
3233
State Street SPDR Dow Jones REIT ETF
RWR
$1.97B
-6
Closed -$1K
RWX icon
3234
State Street SPDR Dow Jones International Real Estate ETF
RWX
$270M
-31
Closed -$1K
RXRX icon
3235
Recursion Pharmaceuticals
RXRX
$1.73B
-151
Closed -$3K
RXT icon
3236
Rackspace Technology
RXT
$1.24B
$0 ﹤0.01%
19
+7
+58% +$83
RYAM icon
3237
Rayonier Advanced Materials
RYAM
$610M
$0 ﹤0.01%
+15
New +$91
RYZ
3238
Ryerson Holding Corp
RYZ
$1.46B
$0 ﹤0.01%
+5
New +$136
RYTM icon
3239
Rhythm Pharmaceuticals
RYTM
$7.96B
-50
Closed
SAGE
3240
DELISTED
Sage Therapeutics
SAGE
-176
Closed -$7K
SAH icon
3241
Sonic Automotive
SAH
$2.61B
-6
Closed
FLNA
3242
Filana Therapeutics
FLNA
$48.1M
$0 ﹤0.01%
10
-2
-17% -$85
SDGR icon
3243
Schrodinger
SDGR
$1.36B
$0 ﹤0.01%
8
-20
-71% -$608
SGMO
3244
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-118
Closed -$1K
SHC icon
3245
Sotera Health
SHC
$5.38B
-84
Closed -$2K
SHM icon
3246
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
-22,194
Closed -$1.09M
SIGA icon
3247
SIGA Technologies
SIGA
$219M
-795
Closed -$6K
SLDB icon
3248
Solid Biosciences
SLDB
$900M
$0 ﹤0.01%
+7
New +$124
SLE icon
3249
Super League Enterprise
SLE
$4.65M
0
-$2K
SLP icon
3250
Simulations Plus
SLP
$371M
$0 ﹤0.01%
7

Similar funds

Parallel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q1 2022 filing shows 219 new, 908 increased, 1,468 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
  • Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
  • Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
  • Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
  • Parallel Advisors opened 219 new positions and closed 292 in Q1 2022.
  • Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.